Drug Research
J&J Identifies Lead COVID-19 Vaccine Candidate, Commits to Supply 1 Billion Vaccines Worldwide
Johnson & Johnson is moving forward with a vaccine candidate for COVID-19. The healthcare giant said it selected a lead vaccine candidate and plans to begin human testing in September, with first batches available under potential emergency use authorization...
Drug Research
Destroying DNA to Save the Genome – Study Offers New Insights into Sepsis and its Treatment
Sepsis is a life-threatening condition that kills millions annually; it is poorly understood and has no specific treatment. Now, researchers from Tata Memorial Centre, India, led by Prof. Dr Indraneel Mittra, have uncovered an important molecular mechanism underlying different...
Drug Research
C2 PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment
C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of the active pharmaceutical ingredient (API), Digoxin. In early March, the API was listed for...
Articles
Leveraging synergies in pre-clinical biomedical R&D – pharmaceutical companies benefit from new innovation models
Introduction: As the complexity of pharmaceutical research and development increases constantly, its innovation productivity defined as the successful approval and launch of truly novel drugs and therapies, has declined since years. To boost its innovation productivity,the pharma industry has...
Drug Research
Univercells launches cell & gene therapy CMDO Exothera with GMP capabilities in 15,000m2 site in Jumet, Belgium
Univercells has launched a contract development and manufacturing organization (CDMO), Exothera, to support cell and gene therapy developers with process development and production of viral vectors. The company has been created to help alleviate the two most critical challenges...
Drug Research
Coronavirus Drug Development Update from NanoViricides, Inc
NanoViricides, Inc. a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, is providing an update on its efforts towards drug development for the current novel coronavirus SARS-CoV-2 that causes COVID-19.
The Company has...
Drug Research
Sinclair Research Announces Toxicology Laboratory Expansion
Sinclair Research, a leading provider of nonclinical contract research services, will officially open its 20,000-square-foot laboratory expansion later this spring. The additional capacity will support GLP nonclinical toxicology research studies to meet the growing demand from pharmaceutical customers for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
